National Center for Injury Prevention and Control Initial Review Group, 19983-19984 [2010-8731]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 73 / Friday, April 16, 2010 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immunology Mechanism.
Date: May 27, 2010.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Patrick K. Lai, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, laip@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 12, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–8811 Filed 4–15–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
National Registry of Genetically Triggered
Thoracic Aortic Aneurysms and
Cardiovascular Conditions (GenTAC).
Date: May 12, 2010.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Chang Sook Kim, PhD,
scientific Review Officer, Review Branch,
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7190, Bethesda, MD
20892, 301–435–0314, carolko@mail.nih.gov.
VerDate Nov<24>2008
15:07 Apr 15, 2010
Jkt 220001
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Interagency Registry for Mechanically
Assisted Circulatory Support (INTERMACS).
Date: May 13, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Holly K Krull, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892–7924, 301–435–0280,
krullh@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Cardiovascular Outcomes Research
Coordinating Unit.
Date: May 25, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriot Suites, 6711
Democracy Boulevatd, Bethesda, MD 20817.
Contact Person: Charles Joyce, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196,
Bethesda, MD 20892–7924, 301–435–0288,
cjoyce@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Centers for Cardiovascular Outcomes
Research.
Date: May 25, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriot Suites, 6711
Democracy Boulevatd, Bethesda, MD 20817.
Contact Person: Charles Joyce, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196,
Bethesda, MD 20892–7924, 301–435–0288,
cjoyce@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Functional Modeling of Pediatric Upper
Airway Disorders.
Date: May 27, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Chang Sook Kim, PhD,
Scientific Review Officer, Review Branch,
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7190,
Bethesda, MD 20892, 301–435–0287,
carolko@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute, Special Emphasis Panel,
Short Term Research Training Grants.
Time: May 27, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
19983
Contact Person: Charles Joyce, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7196,
Bethesda, MD 20892–7924, 301–435–0288,
cjoyce@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 12, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–8806 Filed 4–15–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned review group:
Times and Date:
1 p.m.–1:10 p.m., May 3, 2010 (Open).
1:10 p.m.–2:30 p.m., May 3, 2010
(Closed).
Place: Teleconference.
Toll Free: 877–468–4185 Passcode:
2371296.
Status: A portion of this meeting will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Section 10(d)
of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services, and the Director, CDC,
concerning the scientific and technical
merit of grant and cooperative
agreement applications received from
academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct
specific injury research that focuses on
prevention and control.
Matters To Be Discussed: The meeting
will include the reporting and voting of
the peer reviews conducted in response
to Fiscal Year 2010 Requests for
Applications related to the following
individual research announcements: (1)
E:\FR\FM\16APN1.SGM
16APN1
19984
Federal Register / Vol. 75, No. 73 / Friday, April 16, 2010 / Notices
CE 10 001 Preventing Unintentional
Childhood Injuries (R21); (2) CE 10 002
Unintentional Poisoning from
Prescription Drug Overdoses in Adults
(R21); (3) CE 10 003 Research Priorities
in Acute Injury Care (R01); (4) CE 10
005 Research Grants for Preventing
Violence and Violence-Related Injury
(R01) Agenda items are subject to
change as priorities dictate.
FOR FURTHER INFORMATION CONTACT:
Adele Childress, PhD, Acting Director,
Extramural Research Program Office,
National Center for Injury Prevention &
Control and Executive Secretary, NCIPC
IRG, CDC, 4770 Buford Highway, NE,
M/S F–63, Atlanta, Georgia 30341,
telephone 770–488–4233.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: April 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–8731 Filed 4–15–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular Neurosciences.
Date: April 23, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
VerDate Nov<24>2008
15:07 Apr 15, 2010
Jkt 220001
Contact Person: Peter B. Guthrie, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 9, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–8826 Filed 4–15–10; 8:45 am]
BILLING CODE 4140–01–P
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Suite 4069, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Ken D Nakamura, PhD,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: April 8, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–8821 Filed 4–15–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: April 30, 2010.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Camilla E. Day, PhD,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: April 30, 2010.
Time: 2:30 p.m. to 3:30 p.m.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Immunology
Integrated Review Group; Cellular and
Molecular Immunology—B Study Section.
Date: May 27–28, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Hayden, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pathogenic Eukaryotes and their
Vectors.
Date: May 27–28, 2010.
Time: 8:30 a.m. to 5 p.m.
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 75, Number 73 (Friday, April 16, 2010)]
[Notices]
[Pages 19983-19984]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8731]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Injury Prevention and Control Initial Review
Group
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
review group:
Times and Date:
1 p.m.-1:10 p.m., May 3, 2010 (Open).
1:10 p.m.-2:30 p.m., May 3, 2010 (Closed).
Place: Teleconference.
Toll Free: 877-468-4185 Passcode: 2371296.
Status: A portion of this meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5, U.S.C., and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Section 10(d) of Public
Law 92-463.
Purpose: This group is charged with providing advice and guidance
to the Secretary, Department of Health and Human Services, and the
Director, CDC, concerning the scientific and technical merit of grant
and cooperative agreement applications received from academic
institutions and other public and private profit and nonprofit
organizations, including State and local government agencies, to
conduct specific injury research that focuses on prevention and
control.
Matters To Be Discussed: The meeting will include the reporting and
voting of the peer reviews conducted in response to Fiscal Year 2010
Requests for Applications related to the following individual research
announcements: (1)
[[Page 19984]]
CE 10 001 Preventing Unintentional Childhood Injuries (R21); (2) CE 10
002 Unintentional Poisoning from Prescription Drug Overdoses in Adults
(R21); (3) CE 10 003 Research Priorities in Acute Injury Care (R01);
(4) CE 10 005 Research Grants for Preventing Violence and Violence-
Related Injury (R01) Agenda items are subject to change as priorities
dictate.
FOR FURTHER INFORMATION CONTACT: Adele Childress, PhD, Acting Director,
Extramural Research Program Office, National Center for Injury
Prevention & Control and Executive Secretary, NCIPC IRG, CDC, 4770
Buford Highway, NE, M/S F-63, Atlanta, Georgia 30341, telephone 770-
488-4233.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-8731 Filed 4-15-10; 8:45 am]
BILLING CODE 4163-18-P
